돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 3031생성일: 2026년 10월 23일

Benzoic anhydride → methyl(11R,12S,13E,15S)-9-benzoyloxy-11,15-bis(tert-butyldimethylsiloxy)-7-thiaprosta-8,13-dienoate

https://huagongshe.com/ko/reaction/3031

반응식

참여 물질

역할이름HCID투입량
반응물Benzoic anhydrideHCID 7167—
반응물(3S)-1-Iodo-3-(tert-butyldimethylsilyloxy)-1-octeneHCID 11111369—
반응물(4R)-tert-butyldimethylsiloxy-2-(5-methoxycarbonylpentylthio)-2-cyclopenten-1-oneHCID 131720587—
반응물HCID 178418306HCID 178418306—
반응물C6H9CuHCID 178418419—
용매Hexamethylphosphorous triamideHCID 15355—
생성물methyl(11R,12S,13E,15S)-9-benzoyloxy-11,15-bis(tert-butyldimethylsiloxy)-7-thiaprosta-8,13-dienoateHCID 2288380455.4%

반응 단계

Using as the materials and reagents (1E,3S)-1-iodo-3-(tert-butyldimethylsiloxy)-1-octene (442 mg, 1.2 mmol), tert-butyllithium (1.54 mol/l, 1.56 ml, 2.4 mmol), 1-hexynylcopper (174 mg), hexamethylphosphorous triamide (436 μl), (4R)-tert-butyldimethylsiloxy-2-(5-methoxycarbonyl-pentylthio)-2-cyclopenten-1-one (373 mg, 1.0 mmol), and benzoic anhydride (661 mg), the same procedure was performed as in Example 1 to obtain methyl(11R,12S,13E,15S)-9-benzoyloxy-11,15-bis(tert-butyldimethylsiloxy)-7-thiaprosta-8,13-dienoate (239 mg, 33%).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05731452
출처 데이터셋uspto-grants-1998_03
ORD IDord-76d32aafd0e142d0832c397f95f52a05
출처 메모uspto-grants-1998_03